scholarly article | Q13442814 |
P356 | DOI | 10.1111/JTH.12778 |
P698 | PubMed publication ID | 25381723 |
P50 | author | Christine Mannhalter | Q21013476 |
Daniela Dunkler | Q54258757 | ||
Johannes Thaler | Q61086802 | ||
Cihan Ay | Q66126625 | ||
P2093 | author name string | C Marosi | |
C Zielinski | |||
I Pabinger | |||
E-M Reitter | |||
P2860 | cites work | Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C | Q24563608 |
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer | Q33965106 | ||
Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
Venous thromboembolism and cancer: risks and outcomes | Q35157800 | ||
Development and validation of a predictive model for chemotherapy-associated thrombosis | Q36657982 | ||
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial | Q43284608 | ||
Malignancies, prothrombotic mutations, and the risk of venous thrombosis | Q45249091 | ||
High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study | Q45285047 | ||
The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis | Q46443827 | ||
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study | Q48661559 | ||
Prediction of venous thromboembolism in cancer patients. | Q51662626 | ||
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. | Q51773327 | ||
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). | Q53472586 | ||
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. | Q53552275 | ||
Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases | Q54401667 | ||
Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk | Q57192033 | ||
P433 | issue | 1 | |
P921 | main subject | Factor V Leiden | Q185986 |
thrombosis | Q261327 | ||
venous thromboembolism | Q9397786 | ||
P304 | page(s) | 17-22 | |
P577 | publication date | 2014-12-11 | |
P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
P1476 | title | Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS) | |
P478 | volume | 13 |
Q92107537 | Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer |
Q57824763 | Cancer-associated thrombosis: The search for the holy grail continues |
Q51737961 | Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort. |
Q90466730 | Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism |
Q98183400 | Genes and proteins associated with the risk for cancer-associated thrombosis |
Q40577579 | Genetic Risk Factors in Venous Thromboembolism. |
Q37331210 | Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism |
Q47377864 | Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay |
Q52339910 | Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. |
Q91979008 | Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients |
Q55396746 | Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. |
Q98183396 | Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future |
Q38944457 | Venous Thromboembolism in Patients Diagnosed With Lung Cancer |
Q36636558 | Venous thrombosis and cancer: from mouse models to clinical trials. |
Search more.